.rax_tsmdwc_main { float:right; background: ; border: ; padding: 10px; margin:0px 10px 10px 10px; margin-right:0px; } .rax_tsmswc_inner { float:right; margin:0px 10px 10px 10px; margin-right:0px; } .clear { clear:both; } Tweet fbshare
Categories
Subscribe
Archive
-
Recent Posts
Resources
- Autism Speaks - www.autismspeaks.org
- ActToday! -
www.act-today.org - Autism Live -
www.autism-live.com - The A-Word -
www.youtube.com - Mission Possible -
portraits-of-hope.centerforautism.com - Inspire -
www.inspire.com
Prenatal Exposure to Antidepressants and Autism Spectrum Disorders
Participants were identified via the Kaiser Permanente Medical Care Program in Northern California. A total of 298 children with ASD and 1,507 children with typical development were included in the study. Pharmacy records were used to determine maternal antidepressant usage during the year prior to delivery (i.e., the 3 months prior to conception and throughout the gestational period). Antidepressants were classified into three groups: SSRIs, dual-action antidepressants, and tri-cyclic antidepressants.